IL18 and irritable bowel syndrome: IBS is often accompanied by low-level inflammation, resulting from an increased interleukin (IL)18, IL1b, and myeloperoxidase effector production and activity (Aerssens et al., 2009; McKernan et al., 2011; Clarke et al., 2012).